Layer 1

‘Could FMD help patients to learn about their medicines?’

"Scanning a 2D matrix barcode on medicines packaging could help bring PILs to life"

The 2D barcodes on packaging required under EU law could empower patients to access the most recent medicines information online via their smartphones, says Accord’s Tony Cordrey

In a world of mass data and high-speed information flows, access to information is ever-more available and people want to know answers now – not one day, one week, or six months later.

That data must be current and accurate to allow people to make informed decisions about what impacts them. No longer is information only for the limited few.

An example is the patient information leaflet (PIL), which empowers patients with clear comprehensible information about the administration, precautions and potential side effects of their medicine.

This information no longer needs to be a hard copy. As electronic data, it can be easily updated and enhanced for the visually impaired by increasing font sizes and/or voiced.

National guidelines and product licence updates mean that as an industry, manufacturers are constantly updating PILs to align with new developments. In some cases, it might mean that a PIL a patient has in their hand is not the most recent version.

Access to updated online versions of PILs is not new, but it is unlikely that patients would be motivated to search for them, even if they were aware that this was possible. However, the Falsified Medicines Directive (FMD), which came into force on February 9 to protect patients from counterfeit medicines, could give patients an easy way to check their medicines through the 2D matrix code.

As part of the new legislation, all manufacturers are obligated to add 2D matrix codes to packaging. As we know, these codes allow the pharmacist to scan the medication and verify that it is bona fide against a European database.

However, a recent visit from a local school to Accord’s manufacturing site in Fawdon, Newcastle made us think differently about how that technology could be used in the future. If you show a young person a 2D matrix code, they immediately want to get out a mobile phone to scan and read it. They see a code as a conduit to more information.

This got us thinking: what if these codes allowed patients to scan their medication with their smart phones? Not only could they also check and verify their medicines are legitimate, but they could be taken directly to the online PIL, where they would have the most recent information. It should be noted that a counterfeit code is easily photocopied – so how good would it be to check the one on the packaging is the real thing?

PILs are sometimes criticised for being difficult to understand, but 2D codes could link to other interactive resources, such as administration videos and patient advocacy support resources, which could bring them to life. That’s not to mention the benefits that could be gained on the pharmacovigilance side, with the potential for the facility for reporting side effects and improved adherence and the technology linked to reminders to take medication, or to get repeat prescriptions.

We could go further. If we can print 2D matrix codes on medicine packets, then we could envisage printing on blister packs or even onto the tablets themselves. It sounds futuristic, but it could be possible. It’s occurring now in some markets and on some products, but we could do more. It’s so scalable.

There have been discussions about these kinds of digital initiatives, but this 2D technology is the first time that we have something that brings the manufacturer, patient, pharmacy and authorities together to potentially empower patients in a way that we could only have dreamed of.

As with all pioneering technology, such as driverless cars, often the innovation must wait for the regulators to catch up. But we stand on the brink of many exciting possibilities.

Tony Cordrey (pictured) is vice-president of European strategic operations at Accord Healthcare

4 Comments

R A, Community pharmacist

Are we talking about the same cohort of patients who can't take responsibility for managing their own medications i.e. order prescription and ensuring they don't run out?

Charles Whitfield Bott, Pharmacist Director

The core of FMD is rubbish, and I would suggest the biggest threat to Pharmacy in my 20+ years qualified

Angela Channing, Community pharmacist

Totally agree. Is he going to come and scan the boxes in a dozen totes everyday. This is going to be an absolute nightmare. I see and understand what the gentleman is saying and it all sounds wonderful, but who on earth in the UK thought scanning every box was a possibility on the staffing levels we have now, and can't complete the work. And now they give us THIS!  FMD, a new full-time job with no one to do it. No wonder every pharmacy I go to since Feb 9th hasn't scanned anything. Fingers crossed we Leave with No-deal and they turn the data base off for us!! Or it's axed or we secure an opt-out. Personally I don't see how this is physically possible, which is probably why everyone has ignored it !

We’re all doomed, Locum pharmacist

Pity those lacking manual dexterity find it difficult to access their FMD boxed tablets without damaging the packaging. 

Job of the week

Community Pharmacist - Tier 2 provided
South East England, Oxfordshire
Up to £40k per annum - negotiable